万东医疗
(600055)
| 流通市值：125.36亿 | | | 总市值：125.36亿 |
| 流通股本：7.03亿 | | | 总股本：7.03亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 843,329,490.05 | 373,277,998.39 | 1,524,354,161.43 | 1,093,084,824.41 |
| 营业收入 | 843,329,490.05 | 373,277,998.39 | 1,524,354,161.43 | 1,093,084,824.41 |
| 二、营业总成本 | 808,339,870.48 | 358,486,933.72 | 1,361,474,392.59 | 973,078,073.01 |
| 营业成本 | 546,847,151.6 | 232,380,317.2 | 967,141,752.31 | 674,078,721.36 |
| 税金及附加 | 5,974,248.02 | 1,889,477.99 | 14,848,692.83 | 8,428,518.57 |
| 销售费用 | 116,884,599.74 | 60,600,749.81 | 219,402,271.74 | 163,365,259.28 |
| 管理费用 | 53,832,496.4 | 21,820,465.86 | 69,597,988.82 | 57,193,782.68 |
| 研发费用 | 107,291,150.36 | 55,667,880.17 | 165,233,686.54 | 115,518,473.81 |
| 财务费用 | -22,489,775.64 | -13,871,957.31 | -74,749,999.65 | -45,506,682.69 |
| 其中:利息费用 | 385,704.96 | - | 1,646,918.75 | 408,043.94 |
| 其中:利息收入 | 25,501,251.22 | 14,908,321.4 | 72,234,687.01 | 48,867,584.87 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 928,054.79 | 1,430,410.96 | -2,998,534.83 | 1,186,506.84 |
| 加:投资收益 | 1,400,483.41 | -48,753.38 | 6,518,343.78 | 2,917,381.98 |
| 资产处置收益 | -69,616.51 | -61,420.23 | 120,751.58 | 26,630.39 |
| 资产减值损失(新) | - | - | -4,037,692.52 | -4,869 |
| 信用减值损失(新) | -6,227,045.46 | 1,417.32 | -25,427,314.05 | 2,377,444.55 |
| 其他收益 | 27,021,637.35 | 22,773,645.65 | 26,285,260.72 | 12,687,786.46 |
| 四、营业利润 | 58,043,133.15 | 38,886,364.99 | 163,340,583.52 | 139,197,632.62 |
| 加:营业外收入 | - | - | 6,343,723.96 | 1,053,793.53 |
| 减:营业外支出 | - | - | 2,824,674.76 | 1,111,020.28 |
| 五、利润总额 | 58,043,133.15 | 38,886,364.99 | 166,859,632.72 | 139,140,405.87 |
| 减:所得税费用 | 6,338,483.71 | 3,988,709.84 | 8,217,347.42 | 22,514,122.2 |
| 六、净利润 | 51,704,649.44 | 34,897,655.15 | 158,642,285.3 | 116,626,283.67 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 51,704,649.44 | 34,897,655.15 | 158,642,285.3 | 116,626,283.67 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 51,298,644.68 | 35,052,178.64 | 157,350,997.13 | 115,733,364.5 |
| 少数股东损益 | 406,004.76 | -154,523.49 | 1,291,288.17 | 892,919.17 |
| 扣除非经常损益后的净利润 | 35,633,618.97 | 23,268,905.22 | 142,416,193.02 | 111,136,960.31 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.07 | 0.05 | 0.22 | 0.17 |
| (二)稀释每股收益 | 0.07 | 0.05 | 0.22 | 0.17 |
| 八、其他综合收益 | - | - | -1,943,100 | - |
| 归属于母公司股东的其他综合收益 | - | - | -1,943,100 | - |
| 九、综合收益总额 | 51,704,649.44 | 34,897,655.15 | 156,699,185.3 | 116,626,283.67 |
| 归属于母公司股东的综合收益总额 | 51,298,644.68 | 35,052,178.64 | 155,407,897.13 | 115,733,364.5 |
| 归属于少数股东的综合收益总额 | 406,004.76 | -154,523.49 | 1,291,288.17 | 892,919.17 |
| 公告日期 | 2025-08-23 | 2025-04-26 | 2025-03-22 | 2024-10-26 |
| 审计意见(境内) | | | 标准无保留意见 | |